Close

Biotechnology: A Big Word That Means Hope

With biotechnology, nearly 100 new drugs and vaccines have helped millions fight life threatening diseases.

Judah Folkman, Jurgen Drews Keynote Speakers Conference

WASHINGTON, D.C. (Dec. 20, 1999) -- Dr. Judah Folkman, who discovered the process of tumor angiogenesis, and Dr. Jurgen Drews, former president of global research and development for F. Hoffmann-La...

BIO Puts Forth Gene Therapy Oversight Proposal

WASHINGTON, D.C. (Dec. 7, 1999) -- The Biotechnology Industry Organization (BIO) will present alternatives to proposed guidelines for reporting adverse patient events in gene therapy clinical...

The Passing of Bob Swanson

(Carl Feldbaum, president of BIO, today issued the following statement upon the death of Bob Swanson, co-founder of Genentech):

Washington, D.C. (December 6, 1999) -- ôAs a co-founder of...

Sound Evidence, Not Politics or Trade Discrimination Should Be Used to Assess Biotech Foods

(Carl B. Feldbaum, president of the Biotechnology Industry Organization, issued the following statement prior to the start of the World Trade Organization's Third Ministerial Conference in...

Senate Declares January 2000 National Biotechnology Month

See Senate Resolution 200 below

WASHINGTON, D.C. (Nov. 23, 1999) -- The Biotechnology Industry Organization (BIO) applauds the U.S. Senate for...

Biotech Gets Big Boost From Bills Enacted by Congress

WASHINGTON, D.C. (Nov. 22, 1999) -- Included in the 2000 budget legislation passed by Congress are three measures that give a major boost to the biotechnology industry's efforts to develop new life...

Scientific and Food Safety Issues Statement (The Food and Drug Administration Public Meeting)

The Biotechnology Industry Organization (BIO) is pleased to be invited by the Food and Drug Administration (FDA) to participate on the Food Safety Panel for this public meeting. I am L. Val...

Public Information Issues Statement (The Food and Drug Administration Public Meeting)

Thank you for inviting the Biotechnology Industry Organization (BIO) to provide a statement on the Food and Drug Administration's policy on information issues related to products developed...

BIO Supports FDA Public Meetings On Biotech Foods

WASHINGTON, D.C. (Nov. 16, 1999) -- The Biotechnology Industry Organization (BIO) fully concurs with the U.S. Food and Drug Administration's (FDA) initiative to hold public meetings to discuss the...